Smith Anglin Financial, LLC Pfizer Inc Transaction History

Smith Anglin Financial, LLC

$836 Million
Q1 2025

A detailed history of Smith Anglin Financial, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Smith Anglin Financial, LLC holds 10,211 shares of PFE stock, worth $245,370. This represents 0.03% of its overall portfolio holdings.

Number of Shares

10,211

Previous 7,793 31.03%

Holding current value

$245,370

Previous $206,000 25.24%

% of portfolio

0.03%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 09, 2025	BUY	$25.01 - $27.13 $60,474 - $65,600	2,418 Added 31.03%	10,211 $258,000
Q4 2024 Jan 14, 2025	SELL	$24.8 - $30.19 $365,254 - $444,638	-14,728 Reduced 65.4%	7,793 $206,000
Q3 2024 Oct 07, 2024	BUY	$27.7 - $31.39 $13,711 - $15,538	495 Added 2.25%	22,521 $651,000
Q2 2024 Jul 10, 2024	BUY	$25.26 - $29.6 $37,182 - $43,571	1,472 Added 7.16%	22,026 $616,000
Q1 2024 Apr 24, 2024	BUY	$25.89 - $29.73 $277,437 - $318,586	10,716 Added 108.92%	20,554 $570,000
Q4 2023 Jan 17, 2024	SELL	$26.13 - $33.94 $68,120 - $88,481	-2,607 Reduced 20.95%	9,838 $283,000
Q3 2023 Oct 11, 2023	BUY	$32.09 - $37.51 $4,364 - $5,101	136 Added 1.1%	12,445 $412,000
Q2 2023 Jul 10, 2023	BUY	$36.12 - $41.79 $120,749 - $139,703	3,343 Added 37.29%	12,309 $451,000
Q1 2023 Apr 11, 2023	BUY	$39.39 - $51.28 $1,418 - $1,846	36 Added 0.4%	8,966 $365,000
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $24,298 - $31,719	-582 Reduced 6.12%	8,930 $457,000
Q3 2022 Oct 24, 2022	SELL	$43.76 - $53.42 $1,050 - $1,282	-24 Reduced 0.25%	9,512 $416,000
Q2 2022 Jul 25, 2022	BUY	$46.53 - $55.17 $1,302 - $1,544	28 Added 0.29%	9,536 $500,000
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $25,711 - $31,859	-562 Reduced 5.58%	9,508 $492,000
Q4 2021 Jan 31, 2022	BUY	$41.32 - $61.25 $198,088 - $293,632	4,794 Added 90.86%	10,070 $595,000
Q3 2021 Oct 20, 2021	SELL	$39.25 - $50.42 $14,287 - $18,352	-364 Reduced 6.45%	5,276 $227,000
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $202,532 - $229,435	5,640 New	5,640 $221,000
Q1 2021 Jul 08, 2021	SELL	$33.49 - $37.77 $207,403 - $233,909	-6,193 Closed	0 $0
Q4 2020 Jul 08, 2021	BUY	$33.47 - $42.56 $207,279 - $263,574	6,193 New	6,193 $228,000

Others Institutions Holding PFE

# of Institutions

3,370

Shares Held

3.61B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $135B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith Anglin Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smith Anglin Financial, LLC with notifications on news.

Account

Smith Anglin Financial, LLC Pfizer Inc Transaction History